Correction to: Osteoporosis International
10.1007/s00198-017-4351-2
There were two errors in this article.
1. In the section “Ethical considerations”, the registration number of the study was incorrectly given as UMIN000024492. The correct number is UMIN0000 20267.
2. The Acknowledgments paragraph was incomplete. The full text is as follows:
Acknowledgements
The study was funded by Chugai pharmaceuticals co. ltd. Chugai conducted a legal check of the protocol draft, but had no role in any portion of the study, including its design, conduct, data analysis, and manuscript preparation. Akihiro Soga and Hiroo Makimoto of the Department of Pharmacy, Kobe University Hospital (Hyogo, Japan) prepared 42Ca- and 44Ca-enriched compounds, imported by Taiyo Nippon Sanso corporation and Kawaguchi liquefaction chemical corporation. The members of this study group express their sincere gratitude to Midori Hirai M.D., Ph.D, Department of Pharmacy, Kobe University Hospital (Hyogo, Japan) and ken-ichi Furihata M.D., Ph.D., Keikokai medical corporation P-one clinic, Tokyo, Japan for their excellent assistance. The study patients are thanked for their participation.
Footnotes
The online version of the original article can be found at 10.1007/s00198-017-4351-2
Contributor Information
K. Uenishi, Email: uenishi@eiyo.ac.jp
M. Tokiwa, Email: tokiwa@idd-inc.co.jp
S. Kato, Email: shigeaki.kato@iwakimu.ac.jp
M. Shiraki, Email: ripid@bh.wakwak.com